Understanding and interpreting vision safety issues with vigabatrin therapy.
about
Non-vision adverse events with vigabatrin therapy.Applications of optical coherence tomography in pediatric clinical neuroscience.Mechanism of action of vigabatrin: correcting misperceptions.Vigabatrin therapy for refractory complex partial seizures: review of major European trials.Vigabatrin therapy for refractory complex partial seizures: review of clinical trial experience in the United States.Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing.Balancing clinical benefits of vigabatrin with its associated risk of vision loss.Latest American and European updates on infantile spasms.The long-term safety of antiepileptic drugs.Vigabatrin 35 years later - from mechanism of action to benefit-risk considerations.
P2860
Q34068916-30AFDF78-F4BF-4E69-8368-82DCACB5FF5BQ35620366-933E889A-43EE-440F-819F-5B5D4A4CBE18Q37953574-460C1984-B73A-46BF-9658-321543262D78Q37953576-8D859A22-CBAB-4EAD-B080-A30740007C32Q37953578-4E0A3711-6BEE-4329-A7C1-E5A4D29EB461Q37953579-2039DBC2-94A7-4595-AD07-491BF6201AA8Q37953583-89A7192C-E1BE-4A20-A3F0-A7BF89FBEAEFQ38076086-28AFFD2D-2B36-44BD-A486-91F0D21F1848Q38106856-D731E686-5A83-4B3B-9A93-D52E58B41B89Q48552376-58C850C3-09F7-4E64-A916-98EB85628918
P2860
Understanding and interpreting vision safety issues with vigabatrin therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Understanding and interpreting vision safety issues with vigabatrin therapy.
@en
Understanding and interpreting vision safety issues with vigabatrin therapy.
@nl
type
label
Understanding and interpreting vision safety issues with vigabatrin therapy.
@en
Understanding and interpreting vision safety issues with vigabatrin therapy.
@nl
prefLabel
Understanding and interpreting vision safety issues with vigabatrin therapy.
@en
Understanding and interpreting vision safety issues with vigabatrin therapy.
@nl
P2860
P1476
Understanding and interpreting vision safety issues with vigabatrin therapy.
@en
P2093
R C Sergott
P2860
P356
10.1111/J.1600-0404.2011.01601.X
P577
2011-01-01T00:00:00Z